1
|
Maleeva G, Wutz D, Rustler K, Nin-Hill A, Rovira C, Petukhova E, Bautista-Barrufet A, Gomila-Juaneda A, Scholze P, Peiretti F, Alfonso-Prieto M, König B, Gorostiza P, Bregestovski P. A photoswitchable GABA receptor channel blocker. Br J Pharmacol 2019; 176:2661-2677. [PMID: 30981211 PMCID: PMC6609548 DOI: 10.1111/bph.14689] [Citation(s) in RCA: 16] [Impact Index Per Article: 3.2] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/24/2018] [Revised: 03/03/2019] [Accepted: 04/03/2019] [Indexed: 12/26/2022] Open
Abstract
BACKGROUND AND PURPOSE Anion-selective Cys-loop receptors (GABA and glycine receptors) provide the main inhibitory drive in the CNS. Both types of receptor operate via chloride-selective ion channels, though with different kinetics, pharmacological profiles, and localization. Disequilibrium in their function leads to a variety of disorders, which are often treated with allosteric modulators. The few available GABA and glycine receptor channel blockers effectively suppress inhibitory currents in neurons, but their systemic administration is highly toxic. With the aim of developing an efficient light-controllable modulator of GABA receptors, we constructed azobenzene-nitrazepam (Azo-NZ1), which is composed of a nitrazepam moiety merged to an azobenzene photoisomerizable group. EXPERIMENTAL APPROACH The experiments were carried out on cultured cells expressing Cys-loop receptors of known subunit composition and in brain slices using patch-clamp. Site-directed mutagenesis and molecular modelling approaches were applied to evaluate the mechanism of action of Azo-NZ1. KEY RESULTS At visible light, being in trans-configuration, Azo-NZ1 blocked heteromeric α1/β2/γ2 GABAA receptors, ρ2 GABAA (GABAC ), and α2 glycine receptors, whereas switching the compound into cis-state by UV illumination restored the activity. Azo-NZ1 successfully photomodulated GABAergic currents recorded from dentate gyrus neurons. We demonstrated that in trans-configuration, Azo-NZ1 blocks the Cl-selective ion pore of GABA receptors interacting mainly with the 2' level of the TM2 region. CONCLUSIONS AND IMPLICATIONS Azo-NZ1 is a soluble light-driven Cl-channel blocker, which allows photo-modulation of the activity induced by anion-selective Cys-loop receptors. Azo-NZ1 is able to control GABAergic postsynaptic currents and provides new opportunities to study inhibitory neurotransmission using patterned illumination.
Collapse
Affiliation(s)
- Galyna Maleeva
- INSERM, INS, Institut de Neurosciences des Systèmes, Aix-Marseille University, Marseille, France
| | - Daniel Wutz
- Institute of Organic Chemistry, University of Regensburg, Regensburg, Germany
| | - Karin Rustler
- Institute of Organic Chemistry, University of Regensburg, Regensburg, Germany
| | - Alba Nin-Hill
- Departament de Química Inorgànica i Orgànica (Secció de Química Orgànica) and Institut de Química Teòrica i Computacional (IQTCUB), Universitat de Barcelona, Barcelona, Spain
| | - Carme Rovira
- Departament de Química Inorgànica i Orgànica (Secció de Química Orgànica) and Institut de Química Teòrica i Computacional (IQTCUB), Universitat de Barcelona, Barcelona, Spain.,Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain
| | - Elena Petukhova
- Department of Normal Physiology, Kazan State Medical University, Kazan, Russia
| | - Antoni Bautista-Barrufet
- Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
| | - Alexandre Gomila-Juaneda
- Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain
| | - Petra Scholze
- Department of Pathobiology of the Nervous System, Center for Brain Research, Medical University Vienna, Vienna, Austria
| | - Franck Peiretti
- INSERM 1263, INRA 1260, C2VN, Aix-Marseille Université, Marseille, France
| | - Mercedes Alfonso-Prieto
- Department of Computational Biomedicine, Institute for Advanced Simulations IAS-5 and Institute of Neuroscience and Medicine INM-9, Forschungszentrum Jülich GmbH, Jülich, Germany.,Cécile and Oskar Vogt Institute for Brain Research, Medical Faculty, Heinrich Heine University Düsseldorf, Düsseldorf, Germany
| | - Burkhard König
- Institute of Organic Chemistry, University of Regensburg, Regensburg, Germany
| | - Pau Gorostiza
- Institute for Bioengineering of Catalonia (IBEC), The Barcelona Institute of Science and Technology (BIST), Barcelona, Spain.,Institució Catalana de Recerca i Estudis Avançats (ICREA), Barcelona, Spain.,Network Biomedical Research Center in Biomaterials, Bioengineering and Nanomedicine (CIBER-BBN), Spain
| | - Piotr Bregestovski
- INSERM, INS, Institut de Neurosciences des Systèmes, Aix-Marseille University, Marseille, France.,Department of Normal Physiology, Kazan State Medical University, Kazan, Russia.,Institute of Neurosciences, Kazan State Medical University, Kazan, Russia
| |
Collapse
|
2
|
Babiec WE, Faull KF, Feldman JL. Cyclothiazide-induced persistent increase in respiratory-related activity in vitro. J Physiol 2012; 590:4897-915. [PMID: 22753547 DOI: 10.1113/jphysiol.2012.232421] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/30/2023] Open
Abstract
Hypoglossal (XII) motoneurons (MNs) innervate the genioglossus muscle of the tongue, which plays an important role in maintaining upper airway patency, particularly during sleep, and modulating upper airway resistance. Discovering methods for inducing long-term increases in genioglossal motoneuronal excitability to AMPA-mediated drive may help in the development of therapeutics for upper airway motor disorders such as obstructive sleep apnoea. We show that the diuretic, anti-hypertensive, AMPA receptor modulator cyclothiazide (CTZ) induces a profound and long-lasting increase in the amplitude of respiratory-related XII nerve activity in rhythmically active neonatal rat medullary slices. Treatment of the slice with CTZ (90 μM) for 1 h increased the integrated XII ( XII) nerve burst amplitude to 262 ± 23% of pre-treatment control at 1 h post-treatment;much of this increase lasted at least 12 h. The amount of CTZ-induced facilitation (CIF) was dependent upon both CTZ dose and exposure time and was accompanied by a long-lasting increase in endogenous AMPA-mediated drive currents to XII MNs. CIF, however, is not a form of plasticity and does not depend on AMPA or NMDA receptor activation for its induction. Nor does it depend on coincident protein kinase A or C activity. Rather, measurement of mEPSCs along with mass spectrometric analysis of CTZ-treated slices indicates that the cause is prolonged bioavailability of CTZ. These results illustrate a latent residual capacity for potentiating AMPA-mediated inspiratory drive to XII MNs that might be applied to the treatment of upper airway motor deficits.
Collapse
Affiliation(s)
- Walter E Babiec
- Department of Physiology, David Geffen School of Medicine, UCLA, Box 951751, C8-161 NPI, Los Angeles,CA 90095-1751, USA.
| | | | | |
Collapse
|
3
|
Jones SM, Palmer MJ. Pharmacological analysis of the activation and receptor properties of the tonic GABA(C)R current in retinal bipolar cell terminals. PLoS One 2011; 6:e24892. [PMID: 21949779 PMCID: PMC3174224 DOI: 10.1371/journal.pone.0024892] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2011] [Accepted: 08/22/2011] [Indexed: 11/29/2022] Open
Abstract
GABAergic inhibition in the central nervous system (CNS) can occur via rapid, transient postsynaptic currents and via a tonic increase in membrane conductance, mediated by synaptic and extrasynaptic GABAA receptors (GABAARs) respectively. Retinal bipolar cells (BCs) exhibit a tonic current mediated by GABACRs in their axon terminal, in addition to synaptic GABAAR and GABACR currents, which strongly regulate BC output. The tonic GABACR current in BC terminals (BCTs) is not dependent on vesicular GABA release, but properties such as the alternative source of GABA and the identity of the GABACRs remain unknown. Following a recent report that tonic GABA release from cerebellar glial cells is mediated by Bestrophin 1 anion channels, we have investigated their role in non-vesicular GABA release in the retina. Using patch-clamp recordings from BCTs in goldfish retinal slices, we find that the tonic GABACR current is not reduced by the anion channel inhibitors NPPB or flufenamic acid but is reduced by DIDS, which decreases the tonic current without directly affecting GABACRs. All three drugs also exhibit non-specific effects including inhibition of GABA transporters. GABACR ρ subunits can form homomeric and heteromeric receptors that differ in their properties, but BC GABACRs are thought to be ρ1-ρ2 heteromers. To investigate whether GABACRs mediating tonic and synaptic currents may differ in their subunit composition, as is the case for GABAARs, we have examined the effects of two antagonists that show partial ρ subunit selectivity: picrotoxin and cyclothiazide. Tonic and synaptic GABACR currents were differentially affected by both drugs, suggesting that a population of homomeric ρ1 receptors contributes to the tonic current. These results extend our understanding of the multiple forms of GABAergic inhibition that exist in the CNS and contribute to visual signal processing in the retina.
Collapse
Affiliation(s)
- Stefanie M. Jones
- Neuroscience Group, Institute for Science and Technology in Medicine, Keele University, Keele, United Kingdom
| | - Mary J. Palmer
- Neuroscience Group, Institute for Science and Technology in Medicine, Keele University, Keele, United Kingdom
- * E-mail:
| |
Collapse
|
4
|
Martínez-Delgado G, Estrada-Mondragón A, Miledi R, Martínez-Torres A. An Update on GABAρ Receptors. Curr Neuropharmacol 2011; 8:422-33. [PMID: 21629448 PMCID: PMC3080597 DOI: 10.2174/157015910793358141] [Citation(s) in RCA: 32] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/12/2009] [Revised: 04/08/2010] [Accepted: 06/21/2010] [Indexed: 01/29/2023] Open
Abstract
The present review discusses the functional and molecular diversity of GABAρ receptors. These receptors were originally described in the mammalian retina, and their functional role in the visual pathway has been recently elucidated; however new studies on their distribution in the brain and spinal cord have revealed that they are more spread than originally thought, and thus it will be important to determine their physiological contribution to the GABAergic transmission in other areas of the central nervous system. In addition, molecular modeling has revealed peculiar traits of these receptors that have impacted on the interpretations of the latest pharmacolgical and biophysical findings. Finally, sequencing of several vertebrate genomes has permitted a comparative analysis of the organization of the GABAρ genes.
Collapse
Affiliation(s)
- Gustavo Martínez-Delgado
- Instituto de Neurbiología, Departamento de Neurobiología Celular y Molecular, Laboratorio D15, Campus UNAM Juriquilla. Querétaro 76230, México
| | | | | | | |
Collapse
|
5
|
Neurovascular interaction and the pathophysiology of diabetic retinopathy. EXPERIMENTAL DIABETES RESEARCH 2011; 2011:693426. [PMID: 21747832 PMCID: PMC3124285 DOI: 10.1155/2011/693426] [Citation(s) in RCA: 31] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 10/13/2010] [Revised: 01/11/2011] [Accepted: 01/25/2011] [Indexed: 01/08/2023]
Abstract
Diabetic retinopathy (DR) is the most severe of the several ocular complications of diabetes, and in the United States it is the leading cause of blindness among adults 20 to 74 years of age. Despite recent advances in our understanding of the pathogenesis of DR, there is a pressing need to develop novel therapeutic treatments that are both safe and efficacious. In the present paper, we identify a key mechanism involved in the development of the disease, namely, the interaction between neuronal and vascular activities. Numerous pathological conditions in the CNS have been linked to abnormalities in the relationship between these systems. We suggest that a similar situation arises in the diabetic retina, and we propose a logical strategy aimed at therapeutic intervention.
Collapse
|
6
|
Johnston GAR, Chebib M, Hanrahan JR, Mewett KN. Neurochemicals for the investigation of GABA(C) receptors. Neurochem Res 2010; 35:1970-7. [PMID: 20963487 DOI: 10.1007/s11064-010-0271-7] [Citation(s) in RCA: 19] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 09/13/2010] [Indexed: 01/23/2023]
Abstract
GABA(C) receptors are being investigated for their role in many aspects of nervous system function including memory, myopia, pain and sleep. There is evidence for functional GABA(C) receptors in many tissues such as retina, hippocampus, spinal cord, superior colliculus, pituitary and the gut. This review describes a variety of neurochemicals that have been shown to be useful in distinguishing GABA(C) receptors from other receptors for the major inhibitory neurotransmitter GABA. Some selective agonists (including (+)-CAMP and 5-methyl-IAA), competitive antagonists (such as TPMPA, (±)-cis-3-ACPBPA and aza-THIP), positive (allopregnanolone) and negative modulators (epipregnanolone, loreclezole) are described. Neurochemicals that may assist in distinguishing between homomeric ρ1 and ρ2 GABA(C) receptors (2-methyl-TACA and cyclothiazide) are also covered. Given their less widespread distribution, lower abundance and relative structural simplicity compared to GABA(A) and GABA(B) receptors, GABA(C) receptors are attractive drug targets.
Collapse
Affiliation(s)
- Graham A R Johnston
- Adrien Albert Laboratory of Medicinal Chemistry, Department of Pharmacology D06, The University of Sydney, Sydney, NSW 2006, Australia.
| | | | | | | |
Collapse
|
7
|
Abstract
GABAergic feedback inhibition from amacrine cells shapes visual signaling in the inner retina. Rod bipolar cells (RBCs), ON-sensitive cells that depolarize in response to light increments, receive reciprocal GABAergic feedback from A17 amacrine cells and additional GABAergic inputs from other amacrine cells located laterally in the inner plexiform layer. The circuitry and synaptic mechanisms underlying lateral GABAergic inhibition of RBCs are poorly understood. A-type and rho-subunit-containing (C-type) GABA receptors (GABA(A)Rs and GABA(C)Rs) mediate both forms of inhibition, but their relative activation during synaptic transmission is unclear, and potential interactions between adjacent reciprocal and lateral synapses have not been explored. Here, we recorded from RBCs in acute slices of rat retina and isolated lateral GABAergic inhibition by pharmacologically ablating A17 amacrine cells. We found that amacrine cells providing lateral GABAergic inhibition to RBCs receive excitatory synaptic input mostly from ON bipolar cells via activation of both Ca(2+)-impermeable and Ca(2+)-permeable AMPA receptors (CP-AMPARs) but not NMDA receptors (NMDARs). Voltage-gated Ca(2+) (Ca(v)) channels mediate the majority of Ca(2+) influx that triggers GABA release, although CP-AMPARs contribute a small component. The intracellular Ca(2+) signal contributing to transmitter release is amplified by Ca(2+)-induced Ca(2+) release from intracellular stores via activation of ryanodine receptors. Furthermore, lateral nonreciprocal feedback is mediated primarily by GABA(C)Rs that are activated independently from receptors mediating reciprocal feedback inhibition. These results illustrate numerous physiological differences that distinguish GABA release at reciprocal and lateral synapses, indicating complex, pathway-specific modulation of RBC signaling.
Collapse
|
8
|
Jiang Z, Shen W. Role of neurotransmitter receptors in mediating light-evoked responses in retinal interplexiform cells. J Neurophysiol 2009; 103:924-33. [PMID: 20018830 DOI: 10.1152/jn.00876.2009] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022] Open
Abstract
Interplexiform (IP) cells are a long-neglected group of retinal neurons the function of which is yet to be determined. Anatomical study indicates that IP cells are located in the inner nuclear layer, juxtaposed with the third-order neurons. However, the synaptic transmission of IP cells in the inner retina is poorly understood. Using whole cell patch-clamp and pharmacological techniques, we extensively studied synaptic receptors in IP cells. The IP cells in amphibian retinal slices were identified by electrical and morphological properties with voltage-clamp recording and Lucifer yellow dialysis. We find that light-evoked excitatory postsynaptic currents (L-EPSCs) are mediated by AMPA and N-methyl-d-aspartate receptors in IP cells. Although both receptors contributed to the amplitude and kinetics of L-EPSCs, AMPA receptor desensitization substantially shaped L-EPSCs in the neurons, similar to those found in the third-order neurons. The light-evoked inhibitory postsynaptic currents (L-IPSCs) in IP cells were primarily mediated by strychnine-sensitive glycine receptors with a small component of GABA(C) receptors. GABA(C) receptor rho2 subunits were detected in IP cells with single-cell RT-PCR assays. Expression of GABA(C) receptors is one of the special features for IP cells, distinct from most of the third-order neurons that depend on GABA(A) and glycine receptors to relay the inhibitory signals. However, GABA(A) receptors in IP cells acted like nonsynaptic receptors that were activated by exogenous GABA application. Furthermore, L-IPSCs in IP cells were inhibited by the serial inhibitions between amacrine cells in the inner retina. In addition, application of neurotransmitters on the axon terminals of IP cells had no significant current generated in the cells, indicating that the synaptic inputs of IP cells are mainly from the inner retina. This study demonstrates the important role that light signals are encoded by both experiment of inhibitory receptors in IP cells.
Collapse
Affiliation(s)
- Zheng Jiang
- College of Biomedical Science, Florida Atlantic University, Boca Raton, Florida, USA
| | | |
Collapse
|